One of the most puzzling sights in business is a company that has never made a profit being valued at hundreds or thousands of crores. To outsiders it looks like fantasy; to investors it is arithmetic – just arithmetic about the future rather than the present. Valuing an early-stage startup means pricing what the company might become, not what it is. Here is how investors actually do it, which methods they use at each stage, and why the final number is always, in the end, a negotiation.

Why traditional valuation breaks down

The standard tools for valuing mature companies – price-to-earnings ratios, dividend models – need earnings and dividends, which startups do not have. A pre-revenue startup has no profits to multiply and no cash flows to discount with any confidence. So investors shift from valuing the present to pricing the future: they estimate what the company could be worth in five to seven years if things go well, then work backwards, discounting heavily for the enormous risk that things will not. The discount rates used – often 40 to 60 per cent a year for seed-stage companies – reflect a blunt reality: most startups fail, so the winners must pay for the losers.

The methods investors actually use

Several frameworks compete, and experienced investors triangulate between them:

• Revenue multiples: for startups with revenue, investors apply a multiple to annualised revenue – often 5x to 15x for fast-growing tech companies – based on what comparable listed or acquired companies trade at.
• Discounted cash flow (DCF): projecting future cash flows and discounting them to today. Rarely trusted alone for early startups, but standard once a company has predictable economics.
• The Berkus method: assigns value to specific risk-reduction milestones – a working prototype, a strong team, early customers – typically up to a capped pre-money valuation.
• Scorecard method: starts from the average valuation of comparable startups in the region and adjusts up or down for team strength, market size, product and competitive position.
• The venture capital method: estimates the exit value in five years, then divides by the target return multiple – if a fund needs 10x and the projected exit is 1,000 crore, today’s post-money valuation is 100 crore.

No single method is treated as truth; investors use two or three and look for convergence.

What really moves the number

Beneath the spreadsheets, a handful of factors dominate. Growth rate beats almost everything – a company doubling revenue yearly commands a far richer multiple than one growing 30 per cent. Market size sets the ceiling: investors pay for a shot at a large outcome, so startups attacking thousand-crore markets are valued more generously than those in small niches. Gross margins matter because they determine how much of each rupee of revenue can eventually become profit – software’s 80 per cent margins justify multiples that a 20-per-cent-margin commerce business never will. Team pedigree, defensibility of the product, and the heat of the funding market all add their premiums or discounts.

Pre-money, post-money and dilution

Founders must grasp one piece of arithmetic: a round’s valuation comes in two flavours. Pre-money is what the company is worth before the new investment; post-money is pre-money plus the investment. If a startup raises 20 crore at a 80-crore pre-money valuation, the post-money value is 100 crore and the new investors own 20 per cent. Convertible instruments – notes and SAFEs common in early rounds – defer the valuation argument to the next priced round, usually with a discount or a valuation cap rewarding the early risk-takers. Understanding this maths is non-negotiable for founders: it determines exactly how much of their company each rupee raised costs.

Why valuation is ultimately a negotiation

For all the methods, early-stage valuation remains what the market will bear. A startup with three term sheets commands a higher valuation than an identical one with none; a celebrated repeat founder raises at multiples a first-timer cannot. Down rounds – raising at a lower valuation than the previous round – are painful but sometimes necessary, and they trigger anti-dilution protections that punish earlier investors and founders alike. The healthiest mindset for founders is to treat valuation as one term among many: a slightly lower valuation with the right investors, clean terms and enough runway beats a headline-grabbing number with onerous clauses every time.

FAQs

What is a unicorn valuation based on?

The billion-dollar tag comes from the price per share in the latest funding round multiplied by total shares. It reflects what the newest investors paid, not a market verdict – private valuations can and do fall.

Can a valuation be too high?

Yes. An inflated valuation sets expectations the company must grow into; missing them makes the next round a down round, which damages morale, triggers investor protections and can cripple hiring.

Compiled by the Khabar 24h Editorial Desk from publicly available sources.